RYTHM (RYM) Investor presentation summary
Event summary combining transcript, slides, and related documents.
Investor presentation summary
16 Jun, 2026Market trends and consumer behavior
THC is becoming mainstream in the U.S., with demand expanding across product formats and retail channels.
Generational shift shows younger adults increasingly choosing THC over alcohol, with more daily THC consumers than alcohol consumers since 2022.
THC is a $35B+ legal industry, projected to grow further as legal channels expand.
1 in 3 Gen Z and Millennials now regularly consume THC-based beverages, marking a shift away from alcohol.
Regulatory landscape and market access
Medical cannabis was rescheduled to Schedule III in April 2026, creating a federal DEA registration pathway for state-licensed operators.
Federal hemp restrictions effective November 2026 will close Farm Bill-enabled access to hemp-derived THC, restricting products outside state-licensed systems.
Adult-use cannabis remains under a separate federal process, with a decision expected by end of 2026.
State programs continue to drive legal THC access, favoring operators with licensing and compliance expertise.
Business model and brand portfolio
Operates a portfolio of leading THC brands distributed nationally through both state-regulated and hemp-derived channels.
Generates $70M+ in annual licensing revenue from regulated cannabis channels.
Brands are available in over 1,600 dispensaries across 14 states and 7,500+ mainstream retail locations.
Brand ownership enables flexibility as regulations evolve, with a focus on trusted, consistent consumer experiences.
Latest events from RYTHM
- All proposals passed as the company targets THC market growth with strong brands and zero debt.RYM
AGM 202616 Jun 2026 - Q1 2026 net income $19.9M, 78% margin, revenue $13.3M, Q2 outlook $22M, strong licensing growth.RYM
Q1 20265 May 2026 - Virtual meeting to elect directors, ratify auditor, and expand equity plan on June 16, 2026.RYM
Proxy filing27 Apr 2026 - Annual meeting to elect directors, ratify auditor, and expand equity plan; Green Thumb holds 50%.RYM
Proxy filing27 Apr 2026 - Q4 revenue up 164% with 75% gross margin; regulatory risks persist for hemp-derived THC.RYM
Q4 20253 Mar 2026 - Regulatory changes threaten the future of a $100M hemp-THC brand offering.RYM
Registration Filing16 Dec 2025 - Shelf registration enables up to $100M in securities for growth, with focus on hemp-derived brands.RYM
Registration Filing16 Dec 2025 - Shareholders to vote on director elections, auditor ratification, and equity plan amendment.RYM
Proxy Filing1 Dec 2025 - Key votes include director elections, reverse stock split, and equity plan expansion.RYM
Proxy Filing1 Dec 2025